FDA Drug recall D-0571-2016
Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
- FDA Drug
- Class III
- terminated
- Published 2016-01-27
On 2016-01-27 the FDA classified a Class III recall of Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60 by Morton Grove Pharmaceuticals, citing super-Potent Drug: Out of Specification Assay test results were reported for stability samples.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0571-2016 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-12-15 |
| Published | 2016-01-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Morton Grove Pharmaceuticals |
| Distribution | US |
Product
Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
Reason
Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.
Identifiers
| code_info | Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0571-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.